FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2026
Back to search
Official data from USPTO
QUBIT PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
07/07/2026
Trademark type
Combined
Nice classes
9, 35, 38, 42
Filing date
04/22/2024
Registration date
04/07/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
34
Owner location
FR
Examiner
KLUWE, CHERYL D
Law office
N80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "QUBIT PHARMACEUTICALS" in stylized font placed to the left of a stylized cross design.
Holders and representatives
Holders
Q. P. (pessoa física)
Representatives
STEVEN J SOLOMON TUCKER ELLIS LLP
Technical classification
Nice Classes
Class 9Class 35Class 38Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable and recorded computer software using artificial intelligence for visualization and modeling of moleculesmolecular interactionsdrug discoverysimulation of drug-target bindingfor the analysis of biomedical datasets; data acquisition and processing apparatus;; downloadable applications for mobile devices for visualization and modeling of moleculesmolecular interactionsdrug discoverysimulation of drug-target bindingfor the analysis of biomedical datasets; electronic databases recorded on computer media for use in the fields of cosmeticshealthmedicinepharmacology and the treatment of illnesses; data files in electronic formatdownloadablenamely data sets containing data concerning cosmeticshealthmedicinepharmacology and the treatment of illnesses; scientifictechnological and educational data sets in electronic formdownloadable; downloadable soundvideo and audiovisual recordings featuring scientifictechnological and educational information in the fields of cosmeticshealthmedicinepharmacology and the treatment of illnesses; downloadable and recorded software for conducting research; downloadable and recorded artificial intelligence and machine learning software for conducting scientific research in the cosmetic and medical fields; downloadable and recorded software for streaming scientific and technological content via the Internet and global communication networks; downloadable and recorded software for disseminating scientific and technological content to mobile digital electronic devices; downloadable and recorded scientific intelligence and monitoring software for visualization and modeling of moleculesmolecular interactionsdrug discoverysimulation of drug-target bindingfor the analysis of biomedical datasets; downloadable and recorded software for scientific and technological data research; downloadable computer software and applications using artificial intelligencemachine learningdeep learningreinforcement learning for use in the development of pharmaceuticals; downloadable and recorded computer softwarecomputer programs featuring algorithms for manipulating data input or received; data processing equipment; downloadable and recorded software for decision-making support; downloadable and recorded software for data analysis in the fields of cosmeticshealthmedicinepharmacology and the treatment of illnesses; downloadable and recorded software for data aggregationanalysis and processing integrating a collective work environment and for shared work and shared use of resources and data; downloadable and recorded software for planningperformingintegratingoptimizing and monitoring the research and development of new productsparticularly new drugs; downloadable and recorded computer simulation software for planningperformanceintegrationoptimization and tracking of research and development of new productsparticularly new drugs; downloadable and recorded collaborative software platforms for collaboration managementparticularly in the scientific and technical fields; downloadable electronic publicationsresearch articlesscientific journalswhite papersreportsconference proceedings featuring quantum computing applicationsartificial intelligence (AI) methodologies for research; all of the aforesaid goods being for use in connection with or relating to scientific research and research in the medical and pharmaceutical fields.
Class 35
Collection of informationparticularly commercial and scientific informationcompilation of scientificcosmetichealthmedical and pharmacology information into computer databases for business purposes; collection of datacommercialscientificcosmetic and health datafor business purposes; Providing consumer product information to customers via the Internet; computerized database management; management of computerized files and records of molecules and formulations for medical and pharmaceutical useas well as medicines and medical and pharmaceutical research; provision of business information services relating to data processing; providing commercial information from on-line databases; organization of business meetingsbusiness meeting planning for establishing commercial collaborations; computer data processing services; compilation of statistical data relating to medical research for business purposes; business networking servicesarranging and commercial management of business collaborations; business project management with respect to commercial businessfeaturing business research and business development collaborations; compilation of scientific and technical information into computer databases; business information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the pharmaceutical and medical fields.
Class 38
Transmission of information and data by electronic communication networks; rental of access time to users of computer programs on data networks; rental of access time to platforms on the Internet enabling the consultationanalysisexchange and sharing of data; rental of access time to databases in global computer networks; all the aforesaid services provided in connection with or relating to scientific research and the pharmaceutical and medical field.
Class 42
Scientific research and scientific analysis of molecules in the field of developing cosmetics and treatments and medicines; medical research servicescomputerized testing and analysis of medical compoundsmedicines and molecules with the purpose of discovering new treatments or improving and optimizing of existing treatments; design of technical and scientific studiesdesignplanning of scientific research studies; designdevelopmentprogrammingconfigurationinstallationmaintenanceupdating and testing of algorithms and computer softwareparticularly for artificial intelligencemolecular modelling and molecular interactions modelingdecision support; designdevelopmentprogrammingconfigurationinstallationmaintenanceupdating and testing of algorithms and computer software and platforms that are used for consultinganalyzingexchanging and sharing dataparticularly in a collaborative work environmentfor use in the fields of cosmeticshealthmedicinepharmacology and the treatment of illnesses; designdevelopmentcompositionupdating and testing of new medicines and new medicine formulas all being scientific research; medical and scientific research for the development of pharmaceutical products for medical or veterinary use; computer database design and developmentdesigning databases for use in the fields of healthmedicinepharmacology and the treatment of illnesses; design of computer databases; development of computer platforms; scientific and technical project study being scientific study and research in the fields of medicinepharmacology and the treatment of illnesses; conducting of engineering surveys; designdevelopment and programming of artificial intelligence software for use in the fields of healthmedicinepharmacology and the treatment of illnesses; software design and development for data captureinputextractionprocessingdisplay and storage systems; consultancy in connection with computer technology; development of computer programsdecision support software; Software as a Service (SaaS) services featuring software for processing and analyzing data in the fields of healthmedicinepharmacology and the treatment of illnesses; computer project management in the field of electronic data processing; hosting of digital contentof computer databasesfor othersin the fields of cosmetichealthmedicinepharmacology and the treatment of illnesses; rental of computer software in the fields of cosmetichealthmedicinepharmacology and the treatment of illnesses; platform as a service (PaaS) featuring computer software platforms for high performance or quantum computingfor pharmaceuticalmedical and scientific research; provision of information relating to scientific technologynamely scientific research information in the field of pharmaceuticals; provision of temporary use of non-downloadable software for data processing and analysis; preparation of technical and scientific reportsproviding technical and scientific information in the field of medical research; scientific research services; research and development services relating to the processing of medical data for third parties; computer programming services for data analysis; pharmaceutical and drug active ingredient discovery services; organizingcoordinatingconducting and monitoring scientific research in the field of cosmeticshealthmedicinepharmacology and the treatment of illnesses; advanced product researchdesign and development in the field of artificial intelligence; research in the field of quantum computing services applied to pharmaceuticalmedical and scientific research; compiling data for scientific research purposes in the pharmaceutical and medical fields; drug discovery services; advisory and information services relating to the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the medical field.
Publications
History of USPTO decisions and trademark events.
37 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/07/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2026
TMBN
TTAB RELEASE CASE TO TRADEMARKS
03/18/2026
OP.T
OPPOSITION TERMINATED NO. 999999
03/18/2026
OP.S
OPPOSITION SUSTAINED NO. 999999
03/18/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/12/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/27/2026
RFNP
REFUSAL PROCESSED BY IB
12/05/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/08/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
11/07/2025
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
11/06/2025
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
11/06/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/30/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/08/2025
PUBO
PUBLISHED FOR OPPOSITION
07/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/05/2025
DOCK
ASSIGNED TO EXAMINER
04/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/14/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/14/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/14/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/14/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/14/2025
RFNT
REFUSAL PROCESSED BY IB
12/29/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/06/2024
RFRR
REFUSAL PROCESSED BY MPU
12/06/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/22/2024
CNRT
NON-FINAL ACTION WRITTEN
11/21/2024
DOCK
ASSIGNED TO EXAMINER
11/04/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/03/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/29/2024
Continuous trademark protection
Get notified about every new filing that threatens QUBIT PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.